| Breakdown ₩ tn | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1.13 | 1.19 | 1.05 | 1.24 | 0.86 | 0.66 | 0.76 | 0.72 | 0.60 | 0.60 |
| Cost of Revenue | 1.01 | 1.06 | 0.89 | 1.08 | 0.73 | 0.52 | 0.59 | 0.51 | 0.47 | 0.51 |
| Gross Profit | 0.12 | 0.13 | 0.17 | 0.16 | 0.13 | 0.14 | 0.18 | 0.21 | 0.13 | 0.09 |
| Selling, General & Administrative | 0.06 | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.06 | 0.05 | 0.05 |
| Operating Income | 0.07 | 0.08 | 0.12 | 0.12 | 0.09 | 0.11 | 0.14 | 0.15 | 0.08 | 0.04 |
| Finance Income | 0.03 | 0.03 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Finance Costs | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| Pretax Income | 0.08 | 0.10 | 0.15 | 0.11 | 0.10 | 0.10 | 0.14 | 0.15 | 0.06 | 0.04 |
| Income Tax Expense | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.04 | 0.04 | 0.02 | 0.01 |
| Net Income | 0.06 | 0.08 | 0.13 | 0.08 | 0.08 | 0.07 | 0.11 | 0.11 | 0.04 | 0.03 |
| Total Comprehensive Income | 0.07 | 0.07 | 0.14 | 0.08 | 0.07 | 0.07 | 0.10 | 0.11 | 0.04 | 0.03 |
| Breakdown ₩ tn | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 1.17 | 1.17 | 1.10 | 0.94 | 0.95 | 0.91 | 0.86 | 0.88 | 0.75 | 0.71 |
| Current Assets | 0.48 | 0.46 | 0.54 | 0.51 | 0.52 | 0.43 | 0.53 | 0.51 | 0.32 | 0.37 |
| Cash & Cash Equivalents | 0.17 | 0.03 | 0.07 | 0.04 | 0.01 | 0.02 | 0.04 | 0.01 | 0.01 | 0.01 |
| Inventories | 0.07 | 0.07 | 0.06 | 0.07 | 0.05 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Trade Receivables | 0.12 | 0.14 | 0.16 | 0.17 | 0.11 | 0.07 | 0.10 | 0.10 | 0.11 | 0.09 |
| Non-current Assets | 0.69 | 0.71 | 0.56 | 0.43 | 0.43 | 0.49 | 0.34 | 0.38 | 0.43 | 0.34 |
| Property, Plant & Equipment | 0.39 | 0.43 | 0.36 | 0.27 | 0.20 | 0.22 | 0.22 | 0.24 | 0.26 | 0.28 |
| Intangible Assets | 0.06 | 0.07 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Total Liabilities | 0.26 | 0.29 | 0.26 | 0.20 | 0.23 | 0.24 | 0.20 | 0.28 | 0.26 | 0.24 |
| Current Liabilities | 0.22 | 0.24 | 0.21 | 0.16 | 0.18 | 0.17 | 0.10 | 0.17 | 0.14 | 0.12 |
| Non-current Liabilities | 0.03 | 0.06 | 0.05 | 0.04 | 0.05 | 0.07 | 0.10 | 0.11 | 0.12 | 0.12 |
| Total Equity | 0.91 | 0.87 | 0.84 | 0.74 | 0.72 | 0.67 | 0.67 | 0.60 | 0.49 | 0.47 |
| Share Capital | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Retained Earnings | 0.73 | 0.71 | 0.67 | 0.57 | 0.53 | 0.48 | 0.46 | 0.41 | 0.31 | 0.29 |
| Breakdown ₩ bn | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activities | 102.4 | 79.3 | 221.6 | 44.4 | 83.8 | 107.3 | 116.6 | 156.4 | 115.5 | 66.5 |
| Cash from Investing Activities | 101.2 | -75.1 | -139.5 | 63.2 | -75.2 | -91.0 | -19.1 | -171.5 | -55.1 | -26.2 |
| Purchase of Property, Plant & Equipment | 10.5 | 32.4 | 112.4 | 91.5 | 24.9 | 35.6 | 24.2 | 19.5 | — | — |
| Cash from Financing Activities | -59.5 | -46.1 | -49.2 | -79.7 | -28.7 | -31.9 | -74.8 | 15.5 | -51.0 | -53.2 |
| Dividends Paid | 38.4 | 38.4 | 38.4 | 38.4 | 38.4 | 47.1 | 57.5 | 19.3 | 19.3 | 21.7 |
| Net Change in Cash | 144.2 | -41.9 | 32.9 | 27.9 | -20.1 | -15.7 | 22.8 | 0.4 | 5.8 | -13.6 |
| Breakdown ₩ bn | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 397.2 | 294.9 | 276.5 | 291.7 | 290.2 | 269.3 | 311.9 | 294.8 | 280.7 | 300.8 |
| Cost of Revenue | 351.2 | 266.5 | 252.4 | 253.3 | 254.6 | 245.2 | 286.7 | 266.1 | 247.5 | 259.7 |
| Gross Profit | 46.0 | 28.4 | 24.1 | 38.4 | 35.6 | 24.0 | 25.2 | 28.7 | 33.3 | 41.1 |
| Selling, General & Administrative | 13.2 | 13.2 | 19.5 | 12.0 | 13.6 | 11.4 | 17.0 | 9.1 | 11.8 | 9.5 |
| Operating Income | 32.8 | 15.2 | 4.6 | 26.4 | 22.0 | 12.6 | 8.2 | 19.6 | 21.5 | 31.5 |
| Finance Income | 3.2 | 3.9 | 9.2 | 10.3 | 4.9 | 9.9 | 9.3 | 4.2 | 5.3 | 7.4 |
| Finance Costs | 7.2 | 2.6 | 5.4 | 0.5 | 1.8 | 4.4 | 6.6 | 2.1 | 0.8 | 0.5 |
| Pretax Income | 30.2 | 17.9 | 1.0 | 36.8 | 23.6 | 18.4 | 10.8 | 23.0 | 27.9 | 38.5 |
| Income Tax Expense | 8.0 | 4.6 | 2.2 | 8.5 | 5.5 | 4.4 | 3.2 | 5.0 | 6.5 | 8.1 |
| Net Income | 22.3 | 13.3 | -1.1 | 28.3 | 18.1 | 14.0 | 7.7 | 18.0 | 21.4 | 30.4 |
| Total Comprehensive Income | 46.9 | 20.2 | 5.7 | 31.3 | 17.7 | 17.0 | -0.1 | 15.9 | 20.2 | 31.2 |
| Breakdown ₩ tn | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 1.29 | 1.18 | 1.17 | 1.16 | 1.11 | 1.14 | 1.17 | 1.04 | 1.11 | 1.13 |
| Current Assets | 0.63 | 0.50 | 0.48 | 0.48 | 0.42 | 0.44 | 0.46 | 0.47 | 0.55 | 0.56 |
| Cash & Cash Equivalents | 0.12 | 0.05 | 0.17 | 0.04 | 0.02 | 0.03 | 0.03 | 0.04 | 0.07 | 0.07 |
| Inventories | 0.08 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.06 | 0.05 | 0.05 |
| Trade Receivables | 0.16 | 0.12 | 0.12 | 0.12 | 0.11 | 0.11 | 0.14 | 0.13 | 0.17 | 0.17 |
| Non-current Assets | 0.66 | 0.69 | 0.69 | 0.68 | 0.69 | 0.70 | 0.71 | 0.57 | 0.56 | 0.57 |
| Property, Plant & Equipment | 0.37 | 0.38 | 0.39 | 0.40 | 0.41 | 0.42 | 0.43 | 0.36 | 0.36 | 0.36 |
| Intangible Assets | 0.06 | 0.06 | 0.06 | 0.07 | 0.07 | 0.07 | 0.07 | 0.01 | 0.01 | 0.01 |
| Total Liabilities | 0.34 | 0.29 | 0.26 | 0.25 | 0.24 | 0.29 | 0.29 | 0.18 | 0.26 | 0.30 |
| Current Liabilities | 0.25 | 0.26 | 0.22 | 0.22 | 0.20 | 0.24 | 0.24 | 0.13 | 0.21 | 0.25 |
| Non-current Liabilities | 0.09 | 0.04 | 0.03 | 0.04 | 0.04 | 0.05 | 0.06 | 0.04 | 0.05 | 0.05 |
| Total Equity | 0.94 | 0.89 | 0.91 | 0.90 | 0.87 | 0.85 | 0.87 | 0.87 | 0.85 | 0.83 |
| Share Capital | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Retained Earnings | 0.73 | 0.70 | 0.73 | 0.73 | 0.70 | 0.68 | 0.71 | 0.70 | 0.68 | 0.66 |
| Breakdown ₩ bn | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activities | 27.4 | 13.9 | 27.3 | 34.0 | 23.2 | 18.0 | 36.3 | -12.8 | 25.6 | 30.2 |
| Cash from Investing Activities | 35.8 | -134.7 | 104.0 | -2.7 | 3.2 | -3.3 | -50.6 | -9.5 | 10.8 | -25.9 |
| Purchase of Property, Plant & Equipment | 2.4 | 1.5 | 3.0 | 2.7 | 1.9 | 3.0 | 4.5 | 11.1 | 5.7 | 11.1 |
| Cash from Financing Activities | 8.3 | 0.7 | -2.1 | -7.4 | -38.6 | -11.3 | -1.8 | -5.3 | -38.1 | -0.9 |
| Dividends Paid | — | — | 0.0 | 0.0 | — | — | 0.0 | 0.0 | — | — |
| Net Change in Cash | 71.5 | -120.2 | 129.1 | 23.9 | -12.2 | 3.4 | -16.1 | -27.6 | -1.6 | 3.4 |
| FY2025 ₩bn | Latest | 1-yr | 3-yr CAGR | 5-yr CAGR | 10-yr CAGR |
|---|---|---|---|---|---|
| Revenue | 1,127.7 | -5.1% | -3.0% | +11.3% | — |
| Operating income | 65.6 | -18.8% | -17.6% | -9.2% | — |
| Net income | 59.2 | -23.6% | -10.2% | -3.4% | — |
| EPS | ₩1,448 | -23.6% | -10.2% | -3.4% | — |
| Operating cash flow | 102.4 | +29.2% | +32.2% | -0.9% | — |
| Shareholders' equity | 908.3 | +3.8% | +7.1% | +6.2% | — |
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2019 |
|---|---|---|---|---|---|---|
| Gross margin | 10.8% | 10.8% | 15.8% | 12.7% | 15.0% | 21.7% |
| Operating margin | 5.8% | 6.8% | 11.5% | 9.5% | 10.8% | 16.1% |
| Net margin | 5.3% | 6.5% | 12.8% | 6.6% | 9.0% | 10.7% |
| Return on equity | 6.6% | 9.0% | 17.1% | 11.2% | 11.2% | 10.5% |
| Return on assets | 5.1% | 6.8% | 13.2% | 8.7% | 8.3% | 7.9% |
| Operating cash flow / revenue | 9.1% | 6.7% | 21.0% | 3.6% | 9.7% | 16.3% |
| Capex / revenue | 0.9% | 2.7% | 10.7% | 7.4% | 2.9% | 5.4% |
| Symbol | Last Price |
|---|---|
| 281740Lake Materials Co., Ltd. | ₩11,060 +0.5% |
| 456040OCI Company Ltd. | ₩79,300 -0.6% |
| 251970Pum-tech Korea Co., Ltd. | ₩55,300 -3.8% |
| 268280Miwon Specialty Chemical | ₩130,700 -1.3% |
| 001570Kumyang Co., Ltd. | ₩9,900 +0.0% |
| 014820Dongwon Systems Corporation | ₩21,700 -2.3% |
| 006650Korea Petro Chemical IND | ₩96,700 +0.3% |
| 006380Capro Corporation | ₩3,660 +0.0% |
| 102710ENF Technology Co., Ltd. | ₩41,950 +2.2% |
| 048410Hyundai Bioscience Co., Ltd. | ₩6,210 +2.6% |